Back

G-CSF associates with poor survival in cutaneous melanoma and promotes metastasis through coordinated effects on macrophages and tumor cells

Nieto-Valle, A.; Barandalla-Revilla, L.; Lopez-Navarro, B.; Barrio-Alonso, C.; de Francisco-Lopez, A.; Aviles-Izquierdo, J. A.; Parra Blanco, V.; Sanchez-Mateos, P.; Samaniego, R.

2026-06-04 cancer biology
10.64898/2026.06.02.729497 bioRxiv
Show abstract

Macrophage-melanoma interactions critically shape the tumor microenvironment, yet the cytokine networks driving this process remain incompletely understood. Among these, colony-stimulating factors--particularly granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF or CSF3)--regulate myeloid cell behavior during cancer progression, although their specific roles in melanoma remain unclear. Using co-culture systems of melanoma and monocyte-derived macrophages, we found that GM-CSF-primed macrophages induced robust G-CSF secretion and concurrent CSF3 upregulation in both cell compartments. Moreover, transcriptomic profiling of patient-derived tumor-associated macrophages (TAMs) confirmed elevated CSF3 and CSF3R expression in metastatic melanoma. Multiplex immunofluorescence analysis of a stage II-IV primary melanoma cohort (n=84) revealed increased G-CSF and CD114 expression in TAMs and tumor cells from patients who subsequently developed metastasis. High G-CSF levels in either TAMs or melanoma cells emerged as an independent prognostic factor for shorter disease-free and overall survival (p < 0.001). Mechanistically, G-CSF activated STAT1/STAT3 signaling in melanoma cells and promoted proliferation and invasion in a CD114-dependent manner. Of note, G-CSF drove monocyte differentiation toward a distinct inflammatory macrophage state characterized by STAT1/STAT3 activation and a pro-invasive secretory profile. Furthermore, melanoma cells conditioned by G-CSF-differentiated macrophages displayed increased in vivo lung colonization and enriched transcriptional programs linked to invasion and proliferation. Collectively, these findings establish the G-CSF/CD114 axis as a potential clinically relevant driver of melanoma metastasis and identify G-CSF as a novel independent prognostic biomarker. HIGHLIGHTSO_LIDespite its extended clinical use, G-CSF role in human melanoma remains undefined. C_LIO_LIHigh G-CSF expression in primary melanomas correlates with poor patient survival. C_LIO_LIG-CSF promotes melanoma cell invasion and proliferation through CD114 signaling. C_LIO_LIG-CSF drives macrophage differentiation toward a pro-tumoral phenotype. C_LIO_LIMelanoma cells conditioned by G-CSF-primed macrophages are more metastatic. C_LI

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Cell Communication and Signaling
51 papers in training set
Top 0.1%
10.5%
2
Oncogene
85 papers in training set
Top 0.1%
9.6%
3
Frontiers in Immunology
638 papers in training set
Top 2%
5.4%
4
Cell Death & Disease
21 papers in training set
Top 0.1%
5.1%
5
The Journal of Pathology
26 papers in training set
Top 0.1%
4.0%
6
Cancer Research
130 papers in training set
Top 0.9%
4.0%
7
OncoImmunology
24 papers in training set
Top 0.2%
4.0%
8
Cancers
213 papers in training set
Top 2%
3.5%
9
Nature Communications
5641 papers in training set
Top 34%
3.4%
10
EMBO Molecular Medicine
95 papers in training set
Top 0.3%
3.2%
50% of probability mass above
11
International Journal of Cancer
49 papers in training set
Top 0.3%
3.2%
12
Journal of Investigative Dermatology
49 papers in training set
Top 0.2%
2.7%
13
Cancer Immunology Research
35 papers in training set
Top 0.4%
2.4%
14
Journal of Clinical Investigation
179 papers in training set
Top 2%
2.1%
15
Cancer Immunology, Immunotherapy
12 papers in training set
Top 0.1%
2.1%
16
Cell Reports
1498 papers in training set
Top 20%
1.7%
17
Theranostics
37 papers in training set
Top 0.6%
1.3%
18
Communications Biology
993 papers in training set
Top 19%
1.3%
19
Journal of Translational Medicine
57 papers in training set
Top 1%
1.1%
20
Journal for ImmunoTherapy of Cancer
75 papers in training set
Top 1%
1.1%
21
Cell Reports Medicine
153 papers in training set
Top 3%
1.1%
22
Scientific Reports
3612 papers in training set
Top 70%
1.0%
23
JCI Insight
277 papers in training set
Top 7%
1.0%
24
Nature Cancer
39 papers in training set
Top 1%
1.0%
25
Journal of Experimental & Clinical Cancer Research
25 papers in training set
Top 0.8%
0.8%
26
British Journal of Cancer
49 papers in training set
Top 2%
0.8%
27
Genome Medicine
183 papers in training set
Top 5%
0.8%
28
Cancer Research Communications
51 papers in training set
Top 2%
0.8%
29
EMBO Reports
263 papers in training set
Top 7%
0.8%
30
Molecular Cancer Research
49 papers in training set
Top 2%
0.6%